Iovance Biotherapeutics: Q4 Earnings Snapshot

SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Wednesday reported a loss of $116.4 million in its fourth quarter.

The San Carlos, California-based company said it had a loss of 45 cents per share.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 44 cents per share.

The biotechnology company posted revenue of $482,000 in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $1.2 million.

For the year, the company reported a loss of $444 million, or $1.89 per share. Revenue was reported as $1.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA